• Explore /
  • Poster
  • / CABIOS trial: A phase Ib study of cabozantinib and nivolumab in combination with abiraterone in patients (pts) with metastatic hormone sensitive prostate cancer (mHSPC).

CABIOS trial: A phase Ib study of cabozantinib and nivolumab in combination with abiraterone in patients (pts) with metastatic hormone sensitive prostate cancer (mHSPC).

Abstract Poster

Authors

null

Jesse Meir Zaretsky

Washington University School of Medicine, Department of Medicine, Division of Oncology, St. Louis, MO

Jesse Meir Zaretsky , Dhruv Bansal , Muhammad Azeem Saeed , Bo Peng , Jingqin Luo , Jessica Klette , Melissa Andrea Reimers , Russell Kent Pachynski

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer– Advanced/Hormone-Sensitive

Clinical Trial Registration Number

NCT04477512

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 5084)

DOI

10.1200/JCO.2023.41.16_suppl.5084

Abstract #

5084

Poster Bd #

178

Abstract Disclosures

Similar Posters

First Author: Xiao X. Wei

First Author: Melissa Andrea Reimers

First Author: Fernando C. Maluf

First Author: Evan Y. Yu